Layoffs
After falling short of analysts’ expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products.
PPD has terminated a number of employees in its HR department, but has provided few details about the job cuts, according to reports.
The company will explore opportunity to close facilities during second half of 2019.
The cuts were expected to save the company $500M.
Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort.
The jobs are being cut because Roche is moving Swiss packaging ops to CMO-divested sites.
It’s not uncommon for companies to announce layoffs in the final months of the year.
As part of a strategic restructuring, Proteostasis is laying off 13 members of its R&D workforce.
X-Spine is shutting down its Ohio facility and terminating the employees between December and February 2018.
PRESS RELEASES
